image
image
user-login
arrow
Herbitab DAILY PHARMA (HAMZA AZIZ VALIULLA)

Herbitab
DAILY PHARMA (HAMZA AZIZ VALIULLA)

Herbitab is a DEVICE Trademark filed on Oct 13, 2022 in MAHARASHTRA through India IP Office.The Trademark is registered to DAILY PHARMA (HAMZA AZIZ VALIULLA) and was filed by attorney.

Herbitab DAILY PHARMA (HAMZA AZIZ VALIULLA) Trademark Information

Application ID

5645338

Status

Objected

Date of Application

Oct 13, 2022

Classes

5

Proprietor(s)

DAILY PHARMA (HAMZA AZIZ VALIULLA)

Type

DEVICE

Registration State

MAHARASHTRA

Country

India

IP Office

MUMBAI

Used Since

10/08/2022

FAQs

The application for Herbitab was made on Oct 13, 2022
The trademark applicant for Herbitab is DAILY PHARMA (HAMZA AZIZ VALIULLA).
Trademark application has been filed under the class(es) 5.
As per IP India, trademark application is on the following stage: Objected.
Listed application Id of Herbitab is 5645338.
Herbitab Trademark is a DEVICE mark.
Disclaimer: Vakilsearch assumes no responsibility or liability for any errors or omissions in the content of this page. The data is derived from mca.gov.in and ipindia.gov.in
bulb
Don’t lose your brand like ”
Our experts are here to assist you in finding a similar trademark.
  • No results found
1 Lakh+
TM Registered since 2011
trademark
star
4.5/5
(19k+ reviews)
google

footer-service

By continuing past this page, you agree to our Terms of Service Cookie Policy Privacy Policy  and  Refund Policy  © - Uber9 Business Process Services Private Limited. All rights reserved.

Uber9 Business Process Services Private Limited, CIN - U74900TN2014PTC098414, GSTIN - 33AABCU7650C1ZM, Registered Office Address - F-97, Newry Shreya Apartments Anna Nagar East, Chennai, Tamil Nadu 600102, India.

Please note that we are a facilitating platform enabling access to reliable professionals. We are not a law firm and do not provide legal services ourselves. The information on this website is for the purpose of knowledge only and should not be relied upon as legal advice or opinion.